Effect of Brivaracetam in Photosensitive Epileptic Subjects

UCB

Status and phase: Completed; Phase 2

Conditions: Epilepsy

Treatments: Drug: Brivaracetam

Study type: Interventional

Funder types: Industry

Identifiers

NCT00401648

N01069

Protocol Number RPCE02D2304

Details and patient eligibility

About

to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• epileptic subjects with generalized PPR

Exclusion criteria

• more than 2 concomitant antiepileptic drugs

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: Single Blind